TITLE

Treating the obese teenager

AUTHOR(S)
Dietz, William; Rolls, Barbara J.; Stice, Eric; Yanovski, Jack A.
PUB. DATE
October 2001
SOURCE
Patient Care;10/15/2001, Vol. 35 Issue 19, p57
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Provides information on the treatment of obesity among teenagers. Discussion on body mass index; Medical screening suggested to assess obesity; Health risk of obesity; Evaluation of weight loss programs.
ACCESSION #
5523763

 

Related Articles

  • The Role of PAI-1 and Adiponectin on the Inflammatory State and Energy Balance in Obese Adolescents with Metabolic Syndrome. Corgosinho, Flavia; Piano, Aline; Sanches, Priscila; Campos, Raquel; Silva, Patricia; Carnier, June; Oyama, Lila; Tock, Lian; Tufik, Sergio; Mello, Marco; Dâmaso, Ana // Inflammation;Jun2012, Vol. 35 Issue 3, p944 

    Obesity is a chronic inflammatory disease and is considered a risk factor for metabolic syndrome. In this study, 57 obese adolescents with and without metabolic syndrome underwent 1 year of weight loss therapy. At baseline, the metabolic syndrome (MS) patients presented higher values of PAI-1...

  • Exenatide Response in an Adolescent's Morbid Obesity. Soriano Sánchez, Ricardo; López Ruiz, Alfonso; Núñez Sánchez, M. Ángeles; García-Talavera Espín, Noelia Victoria; Meoro Avilés, Amparo; Gallego García, María Teresa; del Peso Gilsanz, Cristina; Soriano Palao, José // Pharmacology & Pharmacy;Apr2014, Vol. 5 Issue 4, p419 

    Adolescent obesity is a health problem worldwide. Drug therapy for obesity in children is only acceptable if done within the framework of a comprehensive weight loss, prevention of comorbidities, including health education, changes in lifestyles, diet and exercise. These pharmacological...

  • Weight loss in obese female adolescents affects blood pressure. Hemsley Jr., Stanley E. // American Family Physician;8/1/1995, Vol. 52 Issue 2, p603 

    Reports that weight loss in obese adolescent females is associated with a decline in diastolic blood pressure. Subjects of the study; Type of diet administered to study subjects; Inclusion of nutritional, behavioral and exercise counselling to the program; Weekly monitoring of study subjects;...

  • Clinical Guidelines: Identification, Evaluation, and Treatment of Overweight and Obesity...  // Family Economics & Nutrition Review;1999, Vol. 12 Issue 1, p59 

    Presents treatment strategies which constitute clinical guidelines on overweight and obesity for health professionals. Advantages of weight loss; Goals of weight loss; How to achieve weight loss; Goals for weight loss maintenance.

  • Free to Lose. Foreyt, J.P.; Goodrick, G.K. // Journal of Sport & Exercise Psychology;Sep1994, Vol. 16 Issue 3, p337 

    Summarizes the 1993 study `Response of Free-Living Adults to Behavioral Treatment of Obesity: Attrition and Compliance to Exercise,' by J.P. Foreyt, G.K. Goodrick and others, which appeared in `Behavior Therapy.' Efficacy of weight loss behavioral treatment on overweight free-living...

  • Which weight for weight-based dosage regimens in obese patients? Erstad, Brian L. // American Journal of Health-System Pharmacy;11/1/2002, Vol. 59 Issue 21, p2105 

    Examines the rationale for using a weight other than total body weight for weight-based medication calculations in adult obese patients. Review of terminologies related to weight-based dosage regimens; Rationale for common dosing equations; Effects of obesity on organ function and protein...

  • Endocrine and metabolic disease. Munro, J.F. // British Medical Journal;2/14/1976, Vol. 1 Issue 6006, p388 

    Evaluates the medical management of obesity. Percentage of patients effectively lose weight; Reasons of patients seeking medical advice for obesity; Value of various drugs use in managing obesity.

  • New weight-loss drug.  // FDA Consumer;Jul/Aug96, Vol. 30 Issue 6, p4 

    Reports on a prescription drug called Redux that can be used for weight loss longer than previous anti-obesity products. Food and Drug Administration's approval of the drug on April 29, 1996; Types of patients targeted for the drug; Results of a clinical study on the drug's effectiveness.

  • Obesity and weight loss in children and adolescents: Is there a viable solution? Huber, Joseph H. // Palaestra;Summer95, Vol. 11 Issue 4, p60 

    Looks into the problem of obesity in the United States. Government intervention against unfounded commercial weight loss programs; Possibilities of solving obesity with changes in lifestyle, nutrition and physical activities.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics